Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen

por Kellner, Joshua N., Yvon, Eric, Parmar, Simrit
Publicado 2018

Targeting CLL-1 for acute myeloid leukemia therapy

por Ma, Hongbing, Padmanabhan, Iyer Swaminathan, Parmar, Simrit, Gong, Yuping
Publicado 2019

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials

por Mehta, Rohtesh S., Rezvani, Katayoun, Olson, Amanda, Oran, Betul, Hosing, Chitra, Shah, Nina, Parmar, Simrit, Armitage, Sue, Shpall, Elizabeth J.
Publicado 2015

In-depth analysis of SARS-CoV-2–specific T cells reveals diverse differentiation hierarchies in vaccinated individuals

por Li, Li, Muftuoglu, Muharrem, Liang, Shaoheng, Basyal, Mahesh, LV, Jiangxing, Akdogan, Mehmet Emin, Chen, Ken, Andreeff, Michael, Flowers, Christopher R., Parmar, Simrit
Publicado 2022

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus

por Lyu, Mi-Ae, Tang, Ximing, Khoury, Joseph D., Raso, Maria Gabriela, Huang, Meixian, Zeng, Ke, Nishimoto, Mitsutaka, Ma, Hongbing, Sadeghi, Tara, Flowers, Christopher R., Parmar, Simrit
Publicado 2023

Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells

por Zeng, Ke, Huang, Meixian, Lyu, Mi-Ae, Khoury, Joseph D., Ahmed, Sairah, Patel, Krina K., Dropulić, Boro, Reese-Koc, Jane, Caimi, Paolo F., Sadeghi, Tara, de Lima, Marcos, Flowers, Christopher R., Parmar, Simrit
Publicado 2023

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

por Yang, Hui, Bueso-Ramos, Carlos, DiNardo, Courtney, Estecio, Marcos R, Davanlou, Masoud, Geng, Qi-Rong, Fang, Zhihong, Nguyen, Martin, Pierce, Sherry, Wei, Yue, Parmar, Simrit, Cortes, Jorge, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado 2013

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

por Saenz, Dyana T., Fiskus, Warren, Manshouri, Taghi, Rajapakshe, Kimal, Krieger, Stephanie, Sun, Baohua, Mill, Christopher P., DiNardo, Courtney, Pemmaraju, Naveen, Kadia, Tapan, Parmar, Simrit, Sharma, Sunil, Coarfa, Cristian, Qiu, Peng, Verstovsek, Srdan, Bhalla, Kapil N.
Publicado 2016

Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC

por Decker, William K., Shah, Nina, Xing, Dongxia, Lapushin, Ruth, Li, Sufang, Robinson, Simon N., Yang, Hong, Parmar, Simrit, Halpert, Matthew M., Keating, Michael J., Gribben, John G., Molldrem, Jeffrey J., Shpall, Elizabeth J., Wierda, William G.
Publicado 2012

Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatme...

por Gladstone, Douglas E, Howard, Christopher, Lyu, Mi-Ae, Mock, Jason, Adams, Darryl, Gibbs, Kevin, Li, Li, Huang, Meixian, Zeng, Ke, D'Alessio, Franco, Herlihy, James, Trevino, Sergio, Hari, Parameswaran, Sadeghi, Tara, Parmar, Simrit, Slutsky, Arthur, Mukherjee, Siddhartha
Publicado 2021

Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan

por Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar
Publicado 2017

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

por Pinnix, Chelsea C., Gunther, Jillian R., Fang, Penny, Bankston, Mikaela E, Milgrom, Sarah A., Boyce, David, Lee, Hun Ju, Nair, Ranjit, Steiner, Raphael, Strati, Paolo, Ahmed, Sairah, Iyer, Swaminathan P., Westin, Jason, Parmar, Simrit, Rodriguez, M. Alma, Nastoupil, Loretta, Neelapu, Sattva, Flowers, Christopher, Dabaja, Bouthaina S.
Publicado 2020

Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS

por Gladstone, Douglas E, D'Alessio, Franco, Howard, Christopher, Lyu, Mi-Ae, Mock, Jason R., Gibbs, Kevin W., Abrams, Darryl, Huang, Meixian, Zeng, Ke, Herlihy, James P., Castillo, Sergio T., Bassett, Roland, Sadeghi, Tara, Parmar, Simrit, Flowers, Christopher R., Mukherjee, Siddhartha, Schoenfeld, David, Thall, Peter F., Slutsky, Arthur S.
Publicado 2023

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety...

por Kellner, Joshua N., Delemarre, Eveline M., Yvon, Eric, Nierkens, Stefan, Boelens, Jaap J., McNiece, Ian, Olson, Amanda, Nieto, Yago, Ciurea, Stefan, Popat, Uday, Ahmed, Sairah, Champlin, Richard, Ramos, Jennifer, Nishimoto, Mitsutaka, Ma, Hongbing, Ke, Zeng, Thall, Peter, Khoury, Joseph D., Negrin, Robert, Andersson, Borje, Parmar, Simrit
Publicado 2018

Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity

por Shah, Nina, Martin-Antonio, Beatriz, Yang, Hong, Ku, Stephanie, Lee, Dean A., Cooper, Laurence J. N., Decker, William K., Li, Sufang, Robinson, Simon N., Sekine, Takuya, Parmar, Simrit, Gribben, John, Wang, Michael, Rezvani, Katy, Yvon, Eric, Najjar, Amer, Burks, Jared, Kaur, Indreshpal, Champlin, Richard E., Bollard, Catherine M., Shpall, Elizabeth J.
Publicado 2013

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning in allogeneic stem cell transplantation

por Konopleva, Marina, Benton, Christopher B., Thall, Peter F., Zeng, Zhihong, Shpall, Elizabeth, Ciurea, Stefan, Kebriaei, Partow, Alousi, Amin, Popat, Uday, Anderlini, Paolo, Nieto, Yago, Parmar, Simrit, Qiao, Wei, Chen, Julianne, Rondon, Gabriela, McMullin, Becky, Wang, Rui-Yu, Lu, Hongbo, Schober, Wendy, Woodworth, Glenda, Gulbis, Alison, Cool, Rita, Andreeff, Michael, Champlin, Richard
Publicado 2015

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

por Ueno, Naoto T., Espinosa Fernandez, Jose Rodrigo, Cristofanilli, Massimo, Overmoyer, Beth, Rea, Dan, Berdichevski, Fedor, El-Shinawi, Mohamad, Bellon, Jennifer, Le-Petross, Huong T., Lucci, Anthony, Babiera, Gildy, DeSnyder, Sarah M., Teshome, Mediget, Chang, Edward, Lim, Bora, Krishnamurthy, Savitri, Stauder, Michael C, Parmar, Simrit, Mohamed, Mona M, Alexander, Angela, Valero, Vicente, Woodward, Wendy A.
Publicado 2018

A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation

por Andersson, Borje S., Thall, Peter F., Ma, Junsheng, Valdez, Benigno C., Bassett, Roland, Chen, Julianne, Ahmed, Sairah, Alousi, Amin, Bashir, Qaiser, Ciurea, Stefan, Gulbis, Alison, Cool, Rita, Kawedia, Jitesh, Hosing, Chitra, Kebriaei, Partow, Kornblau, Steve, Myers, Alan, Oran, Betul, Rezvani, Katayoun, Shah, Nina, Shpall, Elizabeth, Parmar, Simrit, Popat, Uday R., Nieto, Yago, Champlin, Richard E.
Publicado 2022

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

por Cherng, Hua-Jay J., Sun, Ryan, Sugg, Bryant, Irwin, Russell, Yang, Haopeng, Le, Cao Cuong, Deng, Qing, Fayad, Luis, Fowler, Nathan H., Parmar, Simrit, Steiner, Raphael, Hagemeister, Fredrick, Nair, Ranjit, Lee, Hun Ju, Rodriguez, Maria, Samaniego, Felipe, Iyer, Swaminathan P., Flowers, Christopher R., Wang, Linghua, Nastoupil, Loretta J., Neelapu, Sattva S., Ahmed, Sairah, Strati, Paolo, Green, Michael R., Westin, Jason
Publicado 2022

Fludarabine with pharmacokinetically-guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

por Andersson, Borje S., Thall, Peter F., Valdez, Benigno C., Milton, Denái R., Al-Atrash, Gheath, Chen, Julianne, Gulbis, Alison, Chu, Diem, Martinez, Charles, Parmar, Simrit, Popat, Uday, Nieto, Yago, Kebriaei, Partow, Alousi, Amin, de Lima, Marcos, Rondon, Gabriela, Meng, Qing H., Myers, Alan, Kawedia, Jitesh, Worth, Laura L., Fernandez-Vina, Marcelo, Madden, Timothy, Shpall, Elizabeth J., Jones, Roy B., Champlin, Richard E.
Publicado 2016